A total of 800 patients received at least one dose of study medicine. The table below
shows the gender and age of these patients.
Patients who received at least one dose of the study medicine(s)
Triple therapy group Tiotropium group
400 patients 400 patients
Female 126 (32%) 131 (33%)
Male 274 (69%) 269 (67%)
Age range (years) 42 to 87 40 to 87
Average age (years) 66 66
For more detailed information about the patients included in this study, see the
scientific results summaries (links to those summaries are provided at the end of this
document).
Where was this study done?
Study sites were in three countries.
Number of patients who received at least one dose of the
study medicine(s)
Poland 400
Russian Federation 198
United States 202
0 100 200 300 400 500
Number of patients